These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3855433

  • 1. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
    Uckun FM, Ramakrishnan S, Houston LL.
    J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
    [Abstract] [Full Text] [Related]

  • 2. Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein.
    Uckun FM, Ramakrishnan S, Houston LL.
    Cancer Res; 1985 Jan; 45(1):69-75. PubMed ID: 3871174
    [Abstract] [Full Text] [Related]

  • 3. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    Ramakrishnan S, Uckun FM, Houston LL.
    J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
    [Abstract] [Full Text] [Related]

  • 4. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
    Montgomery RB, Kurtzberg J, Rhinehardt-Clark A, Haleen A, Ramakrishnan S, Olsen GA, Peters WP, Smith CA, Haynes BF, Houston LL.
    Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM, Stong RC, Youle RJ, Vallera DA.
    J Immunol; 1985 May 15; 134(5):3504-15. PubMed ID: 3884712
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA, Knowles RW, Burns MJ, Broxmeyer HE, Lu L, Lee HM, Kawahata RT, Scannon PJ, Dupont B.
    J Immunol; 1984 Jul 15; 133(1):137-46. PubMed ID: 6609971
    [Abstract] [Full Text] [Related]

  • 17. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
    Gorin NC, Douay L, Laporte JP, Lopez M, Zittoun R, Rio B, David R, Stachowiak J, Jansen J, Cazellas P.
    Cancer Treat Rep; 1985 Sep 15; 69(9):953-9. PubMed ID: 3896482
    [Abstract] [Full Text] [Related]

  • 18. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.
    Uckun FM, Gajl-Peczalska KJ, Kersey JH, Houston LL, Vallera DA.
    J Exp Med; 1986 Feb 01; 163(2):347-68. PubMed ID: 3511171
    [Abstract] [Full Text] [Related]

  • 19. Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins.
    Goldmacher VS, Anderson J, Blättler WA, Lambert JM, Senter PD.
    J Immunol; 1985 Dec 01; 135(6):3648-51. PubMed ID: 2933450
    [Abstract] [Full Text] [Related]

  • 20. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
    Stone MJ, Tong AW, Fay JW, Lee JC.
    Cancer Detect Prev; 1988 Dec 01; 12(1-6):621-35. PubMed ID: 3180147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.